Bortezomib PurCert Analytical Standard [Includes characterization data for Purity and 1H-NMR]
Analytical Standard
Properties
| Water Solubility | Soluble |
| Assay Purity | >=98 % |
| M pt. | 123 °C |
| Form | Solid |
Safety Information
| Hazard Statement(s) | H315,H319,H361fd,H373 |
| Precautionary Statement | P202 - P260 - P264 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| GHS Pictogram |
|
| Signal word | Warning |
| Storage Temp. | -20°C |
| Storage Class | 11 - Combustible Solids |
Description
Application
It is used as an anticancer drug in the treatment of multiple myeloma and mantle cell lymphoma.
Purpose
Its primary purpose is to inhibit proteasome activity disrupting protein degradation and promoting cancer-cell death.
General Description
Bortezomib is a synthetic dipeptide boronic acid derivative and a reversible inhibitor of the 26S proteasome.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |
